TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 SEK)
| Closing information | 2022/03 | 2021/03 | 2020/03 |
| Turnover |
1,264,946
|
2,669,392
|
2,329,296 |
| Earnings before taxes |
59,381
|
1,257,756
|
4,914,002 |
| Total assets |
864,964
|
2,776,470
|
5,642,839 |
| Current assets |
773,613
|
2,685,711
|
5,456,907 |
| Current liabilities |
730,560
|
1,311,116
|
1,575,826 |
| Equity capital |
112,918
|
1,440,393
|
4,017,586 |
| - share capital |
14,039
|
13,903
|
14,989 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2022/03 | 2021/03 | 2020/03 |
| Solvency |
13.1%
|
51.9%
|
71.2% |
| Turnover per employee |
3,614
|
7,627
|
6,655 |
| Profit as a percentage of turnover |
4.7%
|
47.1%
|
211.0% |
| Return on assets (ROA) | |||
| Current ratio |
105.9%
|
204.8%
|
346.3% |
| Return on equity (ROE) |
52.6%
|
87.3%
|
122.3% |
| Change turnover |
-1,430,512
|
508,814
|
-2,492 |
| Change turnover % |
-53%
|
24%
|
0% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/03 | 2021/03 | 2020/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.